1. Medtech Insight
  2. >>Policy & Regulation

Device Giants Stryker And Baxter Embrace A ‘Quality First’ Culture – And Yield Positive Results

 
• By Shawn M. Schmitt

From cutting costs to getting products to market faster, experts at the two companies explain why it pays to keep quality at the fore.

Woman holding blue award prize ribbon.

Medical device manufacturers that foster a culture of quality throughout their organizations and prioritize quality over compliance can reap a bevy of benefits, including initiating fewer recalls and getting product to market quicker.

So says Sara Sulfridge, senior director of quality strategy at device giant Baxter Healthcare Corp., a company whose employees embody a “quality first” mentality that stretches from the manufacturing...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Compliance

More from Policy & Regulation

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 
• By Natasha Barrow

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.